EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudiePragmatische StudieOpen Access

Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial

Digitale Lösung zur Unterstützung von Medikamentenadhärenz und Selbstmanagement bei Patient:innen mit Krebs (SAMSON): Pilot-RCT

Thu Ha Dang iD, Nilmini Wickramasinghe iD, Prem Prakash Jayaraman iD, Kate Burbury iD, Marliese Alexander iD, Ashley Whitechurch iD, Mitchell Dyer iD, Stephen Quinn iD, Abdur Rahim Mohammad Forkan iD, Penelope Schofield iD

JMIR Formative Research · 19.02.2025 · 9 · e65302

DOI: 10.2196/65302 ↗

Auf einen Blick

In einem 12-wöchigen Pilot-RCT wurde SAMSON bei Erwachsenen mit hämatologischen Malignomen als gut akzeptiert und durchführbar bewertet. Hinweise auf Nutzen für die Adhärenz wurden berichtet.

Fragestellung

Testet die digitale Lösung SAMSON Akzeptanz, Machbarkeit und mögliche Effekte zur Unterstützung von Medikamentenadhärenz und Selbstmanagement bei Krebs?

Methode

12-wöchige, 2-armige, unverblindete, pragmatische Pilot-RCT; 1:1-Randomisierung zu SAMSON oder üblicher Versorgung; Online-Fragebögen und App-Daten.

Ergebnisse

33 Patient:innen willigten ein; 31 wurden randomisiert, 28 beendeten die 12 Wochen. SAMSON wurde als hoch akzeptabel bewertet; 13/15 nutzten die App, 14/15 nahmen die MI-Telekonsultationen wahr.

Einschränkungen

Die Studie war als Pilot-RCT angelegt; die meisten Endpunkte beruhen auf kleinen Zahlen.

Schlussfolgerung der Autor:innen

Die Ergebnisse zeigten, dass SAMSON für onkologische HCPs und Patient:innen mit Krebs akzeptabel, nutzbar und hilfreich ist und in realen onkologischen Settings durchführbar erscheint.

Kernaussagen

  • 33 Patient:innen nahmen teil, 31 wurden randomisiert
  • Hohe Akzeptanz und gute Durchführbarkeit in 12 Wochen
  • Weitere große RCT zur klinischen und ökonomischen Wirksamkeit geplant

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Formative Research, online erschienen am 19.02.2025. Verfasst von Thu Ha Dang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia. Hauptthemen laut MEDLINE: Self-Management, Medication Adherence, Mobile Applications, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medication nonadherence is a serious problem in cancer, potentially impacts patients’ health outcomes and health care costs. Although technology-based medication adherence (MA) interventions have emerged, evidence supporting their quality and effectiveness remains limited.

Objective

This study tested the acceptability, feasibility, and potential effects of Safety and Adherence to Medications and Self-care Advice in Oncology (SAMSON), a digital solution designed to support MA and self-management in cancer.

Methods

A 12-week, 2-arm, unblinded, pragmatic pilot randomized controlled trial was conducted. Adults with hematological malignancies who started oral cancer medicines within the last 12 months were recruited from a metropolitan specialized hospital and randomized 1:1 to SAMSON or control (usual care). The SAMSON solution included a smartphone app with tailored alerts and real-time self-care advice, a web-based dashboard for health care professionals (HCPs) to monitor patients’ adherence and symptoms, and motivational interviewing (MI) teleconsultations delivered by oncology nurses and pharmacists at baseline and weeks 1, 4, 8, and 12. Primary outcomes were the patients’ acceptance of SAMSON, measured by the Unified Theory of Acceptance and Use of Technology at 12 weeks, and study feasibility, measured by predefined rates of recruitment, randomization, retention, intervention adherence, and outcome assessment completion. Secondary outcomes were comparison of MA and clinical self-assessments through online questionnaires, including adherence, toxicity self-management, anxiety and depression symptoms, and quality of life, measured at baseline and 12 weeks between the 2 arms. Data retrieved from the SAMSON app (Swinburne University of Technology) was analysed for task completion.

Results

A total of 33 patients (79% of those who were approached) consented to participate in the trial. Of those, 31/33 (94%) completed baseline surveys and were randomized to SAMSON (15/31) and control arms (16/31). Of 31 patients, 28 (90%) completed the 12-week surveys (12 SAMSON and 16 control). Overall, patients rated the SAMSON solution as highly acceptable (13/15, 87% app usage; 14/15, 93% MI teleconsultation delivery). They reported that SAMSON was easy to use (10/12, 83%) and helpful in improving their MA (6/12, 50%). All study HCPs reported the SAMSON solution was helpful in supporting patients’ MA. Patients completed an average of 99 tasks over the 12-week study period (71% of scheduled tasks). Most patients (10/12, 83%) completed all 5 scheduled consultations. All study feasibility measures were higher than the predefined upper thresholds, except the rate of patients’ responses to medication reminders.

Conclusions

The results demonstrated that the SAMSON solution is acceptable, usable, and useful for oncology HCPs and patients with cancer. The SAMSON solution is feasible in real-life oncology settings. Our next steps involve refining the SAMSON solution based on participants’ feedback, conducting a large-scale randomized controlled trial to evaluate its clinical and economic effectiveness, and exploring potential commercialization. Trial Registration Australian New Zealand Clinical Trials Registry ACTRN12623000472673; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385728 International Registered Report Identifier (IRRID) RR2-10.1136/bmjopen-2023-079122

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Self-ManagementMedication AdherenceMobile ApplicationsNeoplasmsHumansFemaleMalePilot ProjectsMiddle AgedAgedAdultTelemedicine

Stichwörter der Autor:innen

RCTSAMSONcancerdigital solutioneHealthhome-based cancer treatmentmHealthmedication adherencemobile healthmobile phoneoncologyoral chemotherapypatient safetypilot studyquality of life

Autor:innen und Institutionen

  • Department of Psychological Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.
  • Health Services Research and Implementation Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Digital Health Cooperative Research Centre, Sydney, Australia.
  • Optus Chair Digital Health, La Trobe University, Melbourne, Australia.
  • Department Health and Bio Statistics, School of Health Sciences and Iverson Health Innovation Research Institute, Swinburne University of Technology, Melbourne, Australia.
  • Epworth Healthcare, Melbourne, Australia.

ORCID-Profile: Thu Ha Dang, Nilmini Wickramasinghe, Prem Prakash Jayaraman, Kate Burbury, Marliese Alexander, Ashley Whitechurch, Mitchell Dyer, Stephen Quinn, Abdur Rahim Mohammad Forkan, Penelope Schofield

Zitieren

APA

Dang, T. H., Wickramasinghe, N., Jayaraman, P. P., Burbury, K., Alexander, M., Whitechurch, A., Dyer, M., Quinn, S., Forkan, A. R. M., & Schofield, P. (2025). Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial. JMIR Formative Research, 9, e65302. https://doi.org/10.2196/65302

Vancouver

Dang TH, Wickramasinghe N, Jayaraman PP, Burbury K, Alexander M, Whitechurch A, et al. Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial. JMIR Formative Research. 2025;9:e65302. doi:10.2196/65302

BibTeX
@article{Dang2025,
  author = {Dang, Thu Ha and Wickramasinghe, Nilmini and Jayaraman, Prem Prakash and Burbury, Kate and Alexander, Marliese and Whitechurch, Ashley and Dyer, Mitchell and Quinn, Stephen and Forkan, Abdur Rahim Mohammad and Schofield, Penelope},
  title = {Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial},
  journal = {JMIR Formative Research},
  year = {2025},
  volume = {9},
  pages = {e65302},
  doi = {10.2196/65302}
}
Kostenlos starten →